medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 5

<< Back Next >>

Med Int Mex 2015; 31 (5)

Acute respiratory distress syndrome secondary to coccidioidomycosis

Vásquez-Revilla HR, Raymundo-Aguilar CA, Revilla-Rodríguez E
Full text How to cite this article

Language: Spanish
References: 13
Page: 616-621
PDF size: 706.68 Kb.


Key words:

Coccidioidomycosis, ARDS, respiratory support, antifungal therapy.

ABSTRACT

Pulmonary coccidioidomycosis is a rare cause of ARDS, but has a nearly 100% mortality. It requires strong clinical suspicion. Radiographic features can help distinguish coccidioidomycosis. Definitive diagnosis is based on the identification of the fungus by culture, tissue or fluid samples. Serologic studies may be useful in identification. Treatment of cocidioidomicosis in Latin America generally consists of fluconazole or itraconazole and/or amphotericin B. Respiratory support with limitation of lung damage by protective ventilation is essential, as the early use of antifungal therapy. It is important knowledge by doctors on the most severe forms of the disease that do allow early diagnosis and provide effective treatment.


REFERENCES

  1. Spinello IM, Munoz A, Johnson RH. Pulmonary coccidioidomycosis. Semin Respir Crit Care Med 2008;29(2):166-173.

  2. Desai NR, McGoey R, Troxclair D, Simeone F, Palomino J. Coccidioidomycosis in noendemic area: case series and review of literature. J La State Med Soc 2010;162:97-103.

  3. Parish J, Blair J. Coccidioidomycosis. Mayo Clin Proc 2008; 83:343-349.

  4. Maroyoqui LA, Figueroa SR. Coccidioidomicosis. Med int Mex 2008;24(2):125-141.

  5. Castañeda R, Laniado R. Coexistencia de tuberculosis y coccidioidomicosis. Presentación de dos casos clínicos. Rev Inst Nal Enf Resp Mex 2002;15:98-101.

  6. Herrera L, Gómez V, Morales J. Coccidioidomicosis: serie de casos. Neumol Cir Torax 2006;65(4):206-213.

  7. Castañón L, Aroch A, Bazán E, Córdova E. Coccidioidomicosis y su escaso conocimiento en nuestro país. Rev Fac Med Univ Nac Autom Mex 2004;47:145-148.

  8. Nobre K, De Souza B, Soares L, Paiva J, Wanke B. Coccidioidomycosis: an unusual cause of acute respiratory distress syndrome. J Pneumol 2003;29(1):45-48.

  9. Galgiani J, Ampel N, Blair J. Coccidioidomycosis. Clin Infect Dis 2005;41:1217-1223.

  10. Cantanzaro A. Coccidioidomycosis. Semin Respir Crit Care Med 2004;25:123-128.

  11. Limper AH, Knox KS, Sarosi GA, Ampel NM, Bennett JE, et al. An official American thoracic society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med 2010;183:96-128.

  12. Arsura E, Kilgore W. Miriary coccidioidomycosis in immunocompetent. Chest 2000;117:404-409.

  13. Arsura E, Bellingshausen P, Kilgore W, Abraham J, Johnson R. Septic shock in coccidioidomycosis. Crit Care Med 1998;26:62-65.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2015;31